Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer Read more about Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer
Apremilast as a Direct Treatment for Mild-to-moderate Plaque Psoriasis Versus Placebo: an Analysis of Clinical Safety and Efficacy Read more about Apremilast as a Direct Treatment for Mild-to-moderate Plaque Psoriasis Versus Placebo: an Analysis of Clinical Safety and Efficacy
Evaluation of VISITAG SURPOINT™ Module With External Processing Unit (EPU) Read more about Evaluation of VISITAG SURPOINT™ Module With External Processing Unit (EPU)
A Study of Lasmiditan (LY573144) Over Four Migraine Attacks Read more about A Study of Lasmiditan (LY573144) Over Four Migraine Attacks
MarginProbe® System U.S. Post-Approval Study Read more about MarginProbe® System U.S. Post-Approval Study
Diabetes Study of Linagliptin and Empagliflozin in Children and Adolescents (DINAMO)TM Read more about Diabetes Study of Linagliptin and Empagliflozin in Children and Adolescents (DINAMO)TM
A Phase 2b Study of UGN-102 for Low Grade Intermediate Risk Non-Muscle-Invasive Bladder Cancer Read more about A Phase 2b Study of UGN-102 for Low Grade Intermediate Risk Non-Muscle-Invasive Bladder Cancer
Registry of Guardant360® Use and Outcomes In People With Advanced Cancer Read more about Registry of Guardant360® Use and Outcomes In People With Advanced Cancer
Open-Label Extension of CP101 Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects With Recurrence of Clostridium Difficile Infection Read more about Open-Label Extension of CP101 Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects With Recurrence of Clostridium Difficile Infection
Novel INXN-4001 Triple Effector Plasmid in Heart Failure Read more about Novel INXN-4001 Triple Effector Plasmid in Heart Failure